Clinical Trial: Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST Trial

U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746271) titled 'Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST Trial' on July 28.

Brief Summary: This is a phase-III multi-center open-label randomized clinical trial of 4,120 individuals between 23 weeks, 0 days and 35 weeks, 6 days gestation with gestational hypertension or preeclampsia without severe features randomized to antihypertensive medication to a target blood pressure (BP) of =160/110 mmHg titrated to a goal of =160/110 mmHg and titrated to a BP goal of <160/110 mmHg. They will receive IV and/or oral anti-hypertensive medication as per local institut...